Ritalin in Brazil: Production, discourse and practices;A ritalina no Brasil: Produções, discursose práticas

Interface: Communication, Health, Education

Volumn 14, Issue 34, 2010, Pages 499-510

  Ortega, Francisco ^a   Barros, Denise ^a   Caliman, Luciana ^b   Itaborahy, Claudia ^a   Junqueira, Lívia ^a   Ferreira, Cláudia Passos ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Attention deficit disorder with hyperactivity; Brazil; Cognitive enhancement; Media; Ritalin

Indexed keywords

EID: 78149442154     PISSN: 14143283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. BARRETT, S. et al. Characteristics of methylphenidate misuse in a university student sample. Can. ). Psychiatry, v.50, n.8, p.457-61, 2005.
2. BARROS, D. Aprimoramento cognitivo farmacológico: grupos focais com universitários. 2009. Dissertação (Mestrado) - Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro. 2009.
3. CALIMAN, L.V. A Biologia moral da atenção: a construção do sujeito desatento. 2006. Tese (Doutorado) - Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio dé Janeiro. 2006.
4. CONRAD, R Expansion: from hyperactive children to adult ADHD. In:-. (Org.). The medicalization of society: on the transformation of human conditions into treatable disorders. Baltimore: Johns Hopkins University Press, 2007. p.46-69.
5. CONRAD, P.; POTTER, D. From hyperactive children to ADHD adults: observations on the expansion of medical categories. Soc. Probl., v.47, n.4, p.559-82, 2000.
6. DUPANLOUP, A. L'Hyperactivité infantile: analyse sociologique d'une controverse socio-médicale. 2004. Tese (Doutorado) - Université de Neuchâtel, Neuchâtel. 2004.
7. EHRENBERG, A. Le culte de la performance. Paris: Hachette Littératures, 1991.
8. FARAH, M. et al. Neurocognitive enhancement: what can we do and what should we do? Nat. Rev. Neurosa., v.5, n.5, p.421-5, 2004.
9. GREELY, H. et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, v.456, n.7223, p.702-5, 2008. Disponível em: 〈http://www.nature.com/ nature/journal/v456/n7223/full/456702a.html. Acesso em: 12 out. 2008.
10. HACKING, I. The looping effect of human kinds. In: SPERBER, D. et al. (Eds.). Causal cognition: an interdisciplinary approach. Oxford University Press: Oxford, 1995. p.351-83.
11. HYLMAN, S. Improving our brains? BioSocieties, v.1, n.1, p.103-11, 2006.
12. ITABORAHY, C. A ritalina no Brasil: uma década de produção, divulgação e consumo. 2009. Dissertação (Mestrado) - Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro. 2009.
13. JOFFE, V Um dia na vida de um adulto com TDA/H. São Paulo: Lemos Editorial, 2005.
14. KESSLER, R.C. et ai. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am. J. Psychiatry, v.163, n.4, p.716-23, 2006.
15. LIMA, C. Somos todos desatentos? O TDA/H e a construção de bioidentidades. Rio de Janeiro: Relume Dumará, 2005.
16. MAHER, B. Poll results: look who's dopping. Nature, v.7188, n.452, p.674-5, 2008.
17. MATTOS, R No mundo da lua: perguntas e respostas sobre transtorno do déficit de atenção com hiperatividade em crianças, adolescentes e adultos. São Paulo: Lemos Editorial, 2005.
18. MILLER, G. Mental health in developing countries: the unseen: mental illness's global toll. Science, v.311, n.5760, p.458-61, 2006.
19. NATIONAL INSTITUTES OF HEALTH - NIH. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consensus Statement, v.16, n.2, p.1-37,1998.
20. OKIE, S. ADHD in adults. N. Engl. J. Med., v.354, n.25, p.2637-41, 2006.
21. ONU. International Narcotics Control Board. Psychotropic substances: statistics for 2006: assessments of annual medical and scientific requirement. 2008. Disponível em: 〈http://www.incb.org/pdf/technical-reports/ psychotropics/2008/psy-2008.pdf Acesso em: 2 dez. 2008.
22. PASTURA, G.; MATTOS, R Efeitos colaterais do metilfenidato. Rev. Psiquiatr. Clin., v.31, n.2, p.100-4, 2004.
23. RACINE, E; FORLINI, C. Cognitive enhancement, lifestyle choice or misuse of prescription drugs? Neuroethics, p.1-4, 2008. Disponível em: 〈http://www.springerlink.com/ content/u22547313857t607〉 Acesso em: 15 mar. 2009.
24. ROSE, N. Disorders without borders? BioSocieties, v.1, n.4, p.465-84, 2006.
25. SAHAKIAN, B.; MOREIN-ZAMIR, S. Professor's little helper. Nature, v.450, n.20, p.1157-9, 2007.
26. SAVULESCU, J. Genetic interventions and the ethics of enhancement of human beings. In: STEINBOCK, B. (Org.). The Oxford handbook on bioethics. Oxford: Oxford University Press, 2006. p.516-35.
27. SENTENTIA, W. Neuroethical considerations: cognitive liberty and converging technologies for improving human cognition. Ann. N. Y. Acad. Sei., v.1013, p.221-8, 2004.
28. SINGH, I. Not just naughty: 50 years of stimulant drug advertising. In: TONE, A.; WATKiNS, E. (Orgs.). Medicating modern America: prescription drugs in history. New York: New York University Press, 2007. p.131-55.
29. SINGH, I. A framework for understanding trends in ADHD diagnoses and stimulant drug treatment: schools and schooling as a case study. BioSocieties, v.1, n.4, p.439-52, 2006.
30. SZOBOT, C. et al. Neuroimagem no transtorno de déficit de atenção/hiperatividade. Rev. Bras. Psiquiatr., v.23, supl.1, p.32-5, 2001.
31. TETER, C. et al. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy, v.26, n.10, p.1501-10, 2006.
32. TÓFOLI, D. País vive febre da 'droga da obediência'. Folha de São Paulo, São Paulo, 15 jan. 2006. Caderno Cotidiano, p.C1.
33. TURNER, D.; SAHAKIAN, B. Neuroethics of cognitive enhancement. BioSocieties, v.1, n.1, p.113-23, 2006.
34. WEISS, M.; MURRAY, C. Assessment and management of attention-deficit hyperactivity disorder in adults. Can. Med. Assoc. )., v.168, n.6, p.715-22, 2003.
35. WOLPE, R Treatment, enhancement, and the ethics of neurotherapeutics. Brain Cogn., V.50, n.3, p.387-95, 2002.